2021 Q3 Form 10-Q Financial Statement
#000126246321000441 Filed on September 08, 2021
Income Statement
Concept | 2021 Q3 | 2021 Q2 | 2020 Q4 |
---|---|---|---|
Revenue | $0.00 | ||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $9.350K | $2.847K | |
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $9.350K | $2.847K | |
YoY Change | |||
Operating Profit | |||
YoY Change | |||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$9.350K | -$2.850K | |
YoY Change | |||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$9.347K | -$2.847K | |
YoY Change | -56.3% | ||
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$136.80 | -$41.70 | |
COMMON SHARES | |||
Basic Shares Outstanding | 68.35M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q3 | 2021 Q2 | 2020 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $0.00 | $0.00 | |
YoY Change | |||
Cash & Equivalents | |||
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $0.00 | $0.00 | |
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $0.00 | $0.00 | |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $0.00 | $0.00 | |
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $960.00 | $822.00 | $0.00 |
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $6.660K | $33.67K | $25.64K |
YoY Change | |||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.660K | $33.67K | $25.64K |
Total Long-Term Liabilities | $0.00 | $0.00 | |
Total Liabilities | $6.660K | $33.67K | |
YoY Change | |||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$10.05M | -$10.04M | |
YoY Change | |||
Common Stock | $68.35K | $68.35K | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$6.656K | -$33.67K | -$25.64K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $0.00 | $0.00 | |
YoY Change |
Cashflow Statement
Concept | 2021 Q3 | 2021 Q2 | 2020 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$9.347K | -$2.847K | |
YoY Change | -56.3% | ||
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$9.210K | -$7.210K | |
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 9.210K | 7.210K | |
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -9.210K | -7.210K | |
Cash From Investing Activities | |||
Cash From Financing Activities | 9.210K | 7.210K | |
Net Change In Cash | 0.000 | 0.000 | |
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | -$9.210K | -$7.210K | |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q2 | us-gaap |
Assets Current
AssetsCurrent
|
0 | USD |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
0 | USD |
CY2021Q2 | us-gaap |
Assets
Assets
|
0 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
0 | USD |
CY2021Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
822 | USD |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
0 | USD |
CY2021Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
68346042 | shares |
CY2021Q2 | us-gaap |
Cash
Cash
|
0 | USD |
CY2020Q4 | us-gaap |
Cash
Cash
|
0 | USD |
CY2021Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
32848 | USD |
CY2021Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2847 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
0 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-25640 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5183 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-30823 | USD |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2847 | USD |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-33670 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-8030 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
0 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
822 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7208 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
0 | USD | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
7208 | USD | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7208 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
0 | USD | |
CY2020Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
25640 | USD |
CY2021Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
33670 | USD |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
25640 | USD |
CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
10000000 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
10000 | USD |
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
10000 | USD |
CY2021Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
68346042 | shares |
CY2021Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
68346 | USD |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
68346 | USD |
CY2021Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
9939684 | USD |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
9939684 | USD |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-10051700 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-10043670 | USD |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-33670 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-25640 | USD |
CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
0 | USD |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
0 | USD |
CY2021Q2 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2020Q2 | us-gaap |
Revenues
Revenues
|
0 | USD |
us-gaap |
Revenues
Revenues
|
0 | USD | |
us-gaap |
Revenues
Revenues
|
0 | USD | |
CY2021Q2 | hraa |
Total Revenue
TotalRevenue
|
0 | USD |
CY2020Q2 | hraa |
Total Revenue
TotalRevenue
|
0 | USD |
hraa |
Total Revenue
TotalRevenue
|
0 | USD | |
hraa |
Total Revenue
TotalRevenue
|
0 | USD | |
CY2020Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
0 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8030 | USD | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
0 | USD | |
CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2847 | USD |
CY2020Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
0 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
8030 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
0 | USD | |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2847 | USD |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
0 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-8030 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
0 | USD | |
CY2021Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2020Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
CY2021Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
68346042 | shares |
CY2020Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
68346042 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
68346042 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
68346042 | shares | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
0 | USD | |
CY2020Q4 | us-gaap |
Cash
Cash
|
0 | USD |
CY2019Q4 | us-gaap |
Cash
Cash
|
0 | USD |
CY2021Q2 | us-gaap |
Cash
Cash
|
0 | USD |
CY2020Q2 | us-gaap |
Cash
Cash
|
0 | USD |
us-gaap |
Interest Paid
InterestPaid
|
0 | USD | |
us-gaap |
Interest Paid
InterestPaid
|
0 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
us-gaap |
Conversion Of Stock Description
ConversionOfStockDescription
|
Each share of HRAA’s common stock was exchanged for the right to receive approximately 1,271 shares of HRAH’s common stock | ||
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
68346042 | shares |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-10051700 | USD |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> |